Sökning: "hemorrhagic complications"
Visar resultat 1 - 5 av 17 avhandlingar innehållade orden hemorrhagic complications.
1. Hemorrhagic and thromboembolic complications following cholecystectomy
Sammanfattning : Laparoscopic cholecystectomy for gallstone disease is one of the most common procedures in the Western world. The overall complication rate is 10%. Whereas most complications are easily managed, bile duct injuries may have devastating consequences. LÄS MER
2. Cerebral complications in infective endocarditis
Sammanfattning : Infective endocarditis (IE) is a life-threatening disease. Cerebral embolization complicates the course in 10-40% of IE episodes. Aims of study were to investigate the frequency of cerebrovascular complications (CVC) in left-sided IE and the influence of protective and risk factors with focus on antiplatelet and anticoagulant therapy. LÄS MER
3. Management of hemorrhagic complications associated with antithrombotic therapy
Sammanfattning : Anticoagulants are used for the prevention and treatment of arterial and venous thromboembolism. Such therapy is always associated with an increased risk of bleeding. Intracranial hemorrhage is the most serious form of anticoagulantsrelated bleeding and caries a high mortality rate. LÄS MER
4. Crosstalk between Inflammation and Coagulation in Acute Pancreatitis - Experimental and Clinical Studies
Sammanfattning : In various inflammatory conditions a close interplay between inflammation and coagulation is known to exist, where coagulation factor VII (FVII) and tissue factor (TF) are considered to be pivotal players. In this thesis the crosstalk between inflammation and coagulation in acute pancreatitis (AP) has been investigated. LÄS MER
5. Bleeding complications after acute coronary syndrome with special reference to intracranial hemorrhage
Sammanfattning : Background: Bleeding complications following acute coronary syndrome (ACS) have attracted considerable attention in recent years. The gradual implementation of new evidence-based treatments in patients with ACS, with a focus on anti-ischemic therapy, has reduced the risk of ischemic events (new myocardial infarction or ischemic stroke) but at the expense of increased bleeding risk. LÄS MER